XOMA royalty-2c.png
XOMA to Host XOMA 358 Clinical Update Webcast and Conference Call on September 15, 2016
06. September 2016 09:00 ET | XOMA Ltd.
BERKELEY, Calif., Sept. 06, 2016 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq:XOMA), a leader in the discovery and development of therapeutic antibodies, announced today it will host a webcast and...
XOMA royalty-2c.png
XOMA Reports Second Quarter 2016 Achievements and Financial Results
03. August 2016 16:01 ET | XOMA Corporation
BERKELEY, Calif., Aug. 03, 2016 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq:XOMA), a leader in the discovery and development of therapeutic antibodies, today announced recent achievements and...
XOMA royalty-2c.png
XOMA Reports First Quarter 2016 Operational Achievements and Financial Results
04. Mai 2016 16:01 ET | XOMA Corporation
BERKELEY, Calif., May 04, 2016 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq:XOMA), a leader in the discovery and development of therapeutic antibodies, today announced recent operational...
American Heart Association Logo
Bypass Surgery More Cost Effective Than Stents for Diabetics Long Term
04. November 2012 21:12 ET | American Heart Association
Study Highlights: Bypass surgery is more cost effective than drug-covered stents for people with diabetes who have multiple clogged heart arteries. Initially, bypass surgery may cost more...
American Heart Association Logo
Bypass Surgery Significantly Better Than Stents for Treating Multiple Blockages in Diabetics
04. November 2012 07:58 ET | American Heart Association
Study Highlights: Patients with diabetes who have multiple clogged heart arteries fared significantly better when treated with bypass surgery than drug-covered stents. These patients were...
American Heart Association Logo
Mitral Valve Repair With Bypass Surgery May Improve Heart Function
29. Februar 2012 13:00 ET | American Heart Association
Study Highlights: Repairing leaky mitral valves at the time of coronary artery bypass graft (CABG) surgery benefited patients with ischemic heart disease. Patients who had the two...